Species Differences in Stereoselective Pharmacokinetics of HSG4112, A New Anti-Obesity Agent

Volume: 12, Issue: 2, Pages: 127 - 127
Published: Feb 3, 2020
Abstract
HSG4112, a racemic drug, is a new anti-obesity agent. In this study, the stereoselective pharmacokinetics of HSG4112 were investigated in rats and dogs, and the underlying mechanism was investigated. The plasma concentrations of HSG4112(S) and HSG4112(R) were quantitated in plasma from rats and beagle dogs after IV and/or oral administration of racemic HSG4112. The concentration of HSG4112(S) was significantly higher than that of HSG4112(R) in...
Paper Details
Title
Species Differences in Stereoselective Pharmacokinetics of HSG4112, A New Anti-Obesity Agent
Published Date
Feb 3, 2020
Volume
12
Issue
2
Pages
127 - 127
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.